CEO Mark Capone describes Myriad’s efforts to ensure that patients have access to our tests because we understand how the tests can transform their lives. “That’s why we’ve put in place some of the leading financial assistance programs in the industry.”

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.